Literature DB >> 27152698

ACANTHAMOEBA ENDOPHTHALMITIS AFTER RECURRENT KERATITIS AND NODULAR SCLERITIS.

Zaid Mammo1, David R P Almeida, Matthew A Cunningham, Eric K Chin, Vinit B Mahajan.   

Abstract

PURPOSE: To describe the clinical course of a patient with Acanthamoeba keratitis, who despite prompt treatment progressed to histopathology-confirmed Acanthamoeba retinitis and endophthalmitis.
METHODS: Case report.
RESULTS: A healthy 30-year-old male wearing soft contact lens was diagnosed with Acanthamoeba keratitis and treated medically and surgically over the course of 1 year with presumed resolution of the infection. Yet, his infection recurred with documented spread to sclerokeratitis, and overwhelming endophthalmitis. Concerns about extra-ocular spread prompted a therapeutic enucleation with histopathologic evidence of Acanthamoeba organisms throughout the globe.
CONCLUSION: This is a case of a severe recurrent Acanthamoeba infection presenting initially as keratitis, followed by sclerokeratitis and histolopathology-confirmed endophthalmitis. This case demonstrates that despite persistent medical and surgical intervention, eradication of organisms may not be possible.

Entities:  

Mesh:

Year:  2017        PMID: 27152698     DOI: 10.1097/ICB.0000000000000323

Source DB:  PubMed          Journal:  Retin Cases Brief Rep        ISSN: 1935-1089


  3 in total

1.  Reactive uveitis, retinal vasculitis and scleritis as ocular end-stage of Acanthamoeba keratitis: a histological study.

Authors:  Lei Shi; Tobias Hager; Fabian Norbert Fries; Loay Daas; Leonard Holbach; Carmen Hofmann-Rummelt; Elena Zemova; Berthold Seitz; Nóra Szentmáry
Journal:  Int J Ophthalmol       Date:  2019-12-18       Impact factor: 1.779

2.  Bilateral Acanthamoeba Panophthalmitis: A rare and unique case.

Authors:  Rati Chkheidze; Bret M Evers; Dominick Cavuoti; James Merritt; R Nick Hogan
Journal:  Am J Ophthalmol Case Rep       Date:  2020-10-16

3.  Surgical management of acanthamoeba chorioretinitis.

Authors:  Kapil Mishra; Gabriel Velez; C Nathaniel Roybal; Vinit B Mahajan
Journal:  Am J Ophthalmol Case Rep       Date:  2022-01-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.